Results 11 to 20 of about 166,677 (165)

Acral melanoma: new insights into the immune and genomic landscape

Neoplasia: An International Journal for Oncology Research, 2023
Acral melanoma is a rare subtype of melanoma that arises on the non-hair bearing skin of the nail bed, palms of the hand and soles of the feet. It is unique among melanomas in not being linked to ultraviolet radiation (UVR) exposure from the sun, and, as
Larissa Anastacio DaCosta Carvalho, Flavia C. Aguiar, Keiran S.M. Smalley, Patricia A. Possik   +3 more
doaj   +2 more sources

Acral Nevi: Dermatoscopic Features and Key Points

Львівський клінічний вісник, 2017
Introduction. Acral nevus is a benign melanocytic proliferation at the palms and soles, which occurs in approximately 4.0 % of people with white skin.
Т. Шулаіа, Н. Кіладзе, А. Булінська, Л. О. Абрагамович   +3 more
doaj   +2 more sources

Managing telomerase and telomere dysfunction in acral melanoma

Pharmacological Research
Acral Lentiginous Melanoma is a rare and aggressive subtype of melanoma that commonly affects the palms, soles, and nail beds. It is more prevalent in individuals with darker skin tones, including Asian, African, and Hispanic populations.
Vishnu Sravan Bollu, Yu-Chi Chen, Fan Zhang, Krishne Gowda, Shantu Amin, Arun K. Sharma, Todd D. Schell, Jiyue Zhu, Gavin P. Robertson   +8 more
doaj   +2 more sources

Acral lentiginous melanoma

Medical Journal of Dr. D.Y. Patil University, 2015
Acral lentiginous melanoma (ALM) is the most common type of melanoma in dark skinned peoples and Asians. The mean age of ALM ranges from 55 to 68 years.
Sachin A Badge, Avinash Meshram, Anjalee Ovhal   +2 more
doaj   +2 more sources

Hyperkeratotic Acral Melanoma Mimicking a Common Wart

Plastic and Reconstructive Surgery, Global Open, 2015
Summary: Acral melanoma is a great pretender; anything but i nfrequently, it adopts clinical faces, simulating skin conditions that make the healthcare provider diagnose it as a benign disease of the palms, soles, and ungual regions. We present a case of
Vincenzo Vindigni, MD, PhD, Carlotta Scarpa, MD, PhD, Franco Bassetto, MD   +2 more
doaj   +3 more sources

Adjuvant Therapy in Acral Melanoma: A Systematic Review [PDF]

Clinical, Cosmetic and Investigational Dermatology
Zhou Zhu,1– 3 Mingjuan Liu,1– 3 Hanlin Zhang,1,2 Heyi Zheng,1,2 Jun Li1,2 1Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China; 2State ...
Zhu Z, Liu M, Zhang H, Zheng H, Li J
doaj   +1 more source

Acral Amelanotic Melanoma Mimicking a Non-Healing Arterial Ulcer [PDF]

Case Reports in Dermatology, 2019
Acral melanomas contribute to approximately 2–3% of melanomas but are commonly misdiagnosed due to their rarity, subtlety at onset and tendency to display amelanotic features.
Phillip Cantwell, Helena Van Dam
doaj   +2 more sources

m6A Methyltransferase METTL3 Promotes the Progression of Primary Acral Melanoma via Mediating TXNDC5 Methylation

Frontiers in Oncology, 2022
m6A modification is one of the most important post-transcriptional modifications in RNA and plays an important role in promoting translation or decay of RNAs.
Zhanghui Yue, Meng Cao, Anlan Hong, Qian Zhang, Guoqiang Zhang, Zhibin Jin, Liang Zhao, Qiang Wang, Fang Fang, Yan Wang, Jianfang Sun   +10 more
doaj   +1 more source

TRPM1 promotes tumor progression in acral melanoma by activating the Ca2+/CaMKIIδ/AKT pathway

Journal of Advanced Research, 2023
Introduction: Acral melanoma is a predominant and aggressive subtype of melanoma in non-Caucasian populations. There is a lack of genotype-driven therapies for over 50% of patients.
Chi-Che Hsieh, Yue-Chiu Su, Kuan-Ying Jiang, Takamichi Ito, Ting-Wei Li, Yumiko Kaku-Ito, Shih-Tsung Cheng, Li-Tzong Chen, Daw-Yang Hwang, Che-Hung Shen   +9 more
doaj   +1 more source

Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis

Cancer Control, 2021
Background Acral lentiginous melanoma is associated with worse survival than other subtypes of melanoma. Understanding prognostic factors for survival and recurrence can help better inform follow-up care.
Avani M. Kolla BPhil, Gerardo A. Vitiello MD, Erica B. Friedman MD, James Sun MD, Aishwarya Potdar MS, Hala Daou BS, Norma E. Farrow MD, Clara R. Farley MD, John T. Vetto MD, Dale Han MD, Marvi Tariq MD, Georgia M Beasley MD, Carlo M. Contreras MD, Michael Lowe MD, Jonathan S. Zager MD, Iman Osman MD, Russell S. Berman MD, Tracey N. Liebman MD, Jennifer A. Stein MD PhD, Ann Y. Lee MD   +19 more
doaj   +1 more source